Onderneming Kiniksa Pharmaceuticals International, plc
Aandelen
KNSA
GB00BRXB0C07
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,24 USD | +0,73% |
|
+3,00% | +9,64% |
26/06 | Sectorupdate: Gezondheidszorgaandelen woensdag gemengd voor de beurs | MT |
24/06 | Kiniksa werkt samen met NHL Hall-of-Fame Henrik Lundqvist aan bewustwordingscampagne over pericarditis | MT |
Vakgebied
Aantal werknemers: 297
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Medicines
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bermuda
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 01-07-15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01-07-15 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 01-05-18 |
Chad Morin
CMP | Compliance Officer | - | 01-10-20 |
John Paolini
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-08-16 |
Rachel Frank
IRC | Investor Relations Contact | - | - |
General Counsel | - | 01-08-20 | |
Ross Moat
PRN | Corporate Officer/Principal | 43 | 01-01-19 |
Martina Struck
LAW | General Counsel | - | 01-01-18 |
Melissa Manno
HRO | Human Resources Officer | - | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 01-10-15 |
Barry Quart
BRD | Director/Board Member | 67 | 01-10-15 |
Thomas Malley
BRD | Director/Board Member | 55 | 01-12-16 |
Richard Levy
BRD | Director/Board Member | 66 | 04-03-19 |
Kim Popovits
BRD | Director/Board Member | 65 | 01-02-18 |
G. Cole
BRD | Director/Board Member | 68 | 27-07-20 |
Stephen Biggar
BRD | Director/Board Member | 53 | 01-10-15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01-07-15 |
Tracey McCain
BRD | Director/Board Member | 56 | 01-02-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 057 618 | 0 | 0 | 54,38 % |
Aandeel B | 1 | 12 781 964 | 0 | 0 | |
Aandeel C | 1 | 1 795 158 | 0 | 0 | |
Aandeel D | 1 | 40 305 405 | 38 579 583 ( 95,72 %) | 0 |
Bedrijfsgegevens
![Adres Kiniksa Pharmaceuticals International, plc(KNSA)](https://cdn.zonebourse.com/static/address/43459706.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,64% | 1,36 mld. | |
+16,81% | 121 mld. | |
+18,25% | 110 mld. | |
+17,23% | 25,98 mld. | |
-24,19% | 19,27 mld. | |
-18,56% | 15,99 mld. | |
-17,89% | 15,66 mld. | |
-47,75% | 14,5 mld. | |
+57,16% | 14,47 mld. | |
+5,97% | 13,91 mld. |
- Beurs
- Aandelen
- Koers KNSA
- Onderneming Kiniksa Pharmaceuticals International, plc